Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Radiotherapy in IDH-wt/TERTp-mut Grade II/III Glioma
NCT02766270Phase 1Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of temozolomide in glioma, sponsored by Beijing Tiantan Hospital. Status: unknown.
02
Drugs
temozolomide
03
Conditions
glioma
Beyond the preview
Go deeper on NCT02766270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02766270.